K-numberK251866
Device nameTegaderm Post-Op Transparent Antimicrobial Dressing
ApplicantSolventum US, LLC
Product codeFRO
Device classClass U
Decision dateOct 10, 2025
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Tegaderm™ Post-Op Transparent Antimicrobial Dressing is a waterproof, sterile, single-use dressing containing 1.2% chlorhexidine gluconate (CHG) gel pad, intended for use by healthcare professionals to cover and protect closed surgical incisions, laparoscopic incisions, and percutaneous devices (such as sutures, staples, or tissue adhesives) in adult patients. The dressing provides a physical barrier against external contamination including fluids, bacteria, mold, and yeast while allowing continual site observation and moisture vapor exchange.

Technological characteristics

The device combines a transparent adhesive film backing with an integrated transparent CHG gel pad that absorbs exudate. Key characteristics include: waterproof barrier protection, antimicrobial effectiveness against gram-positive and gram-negative bacteria, yeast, and mold; breathability allowing moisture vapor transmission; transparency for site observation; adhesion and liner release functionality; and terminal sterilization via ethylene oxide. A predetermined change control plan includes bodily fluid barrier protection testing per ASTM F1670.

Test standards cited

ASTM Method F1670 Synthetic Blood Penetration standard is referenced for future fluid barrier testing under the predetermined change control plan. Applicable standards and guidance documents were used for design and testing, though specific standards for absorption, moisture vapor transmission rate, adhesion, liner release, antimicrobial effectiveness, and transparency testing are listed but not detailed by name.

Substantial equivalence argument

The subject device demonstrates the same or similar performance to key features of the predicate device (ReliaTect™ Post-Op Dressing, K163529) including identical antimicrobial ingredient (CHG), similar antimicrobial effectiveness (4-log reduction across multiple organisms), shared characteristics (waterproof, transparent, sterile, single-use, adhesive, absorbent), and comparable intended use. Although the subject device includes additional mold testing and bodily fluid barrier protection, these do not raise new questions of safety or effectiveness and support that the device is as safe and effective as the legally marketed predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →